Request Sample

Global Small Molecule Drug Discovery Market

Dec. 1, 2019

Global Small Molecule Drug Discovery Market, By Therapeutic Type (Central Nervous System (CNS), Cardiovascular, Oncology, Metabolic Disorders, Gastrointestinal, Orthopedics, Respiratory, Immunology, Others ), By Phase (HIT Generation & Selection, Validation, Lead Identification, Lead Optimization), By Region (North America, Latin America, Europe, Asia-Pacific, and Middle East and Africa) - Global Forecast, 2020-2025.

Report Code : FMR298      
Pages : 210 Pages
Format :   PPT Format   PDF Format

The global small molecule drug discovery market was valued at US$ xx million in the year 2018. This market is estimated to be valued at US$ xx million in the year 2019, and is expected to reach US$ xx million by the year 2025, with an estimated CAGR of xx% during the forecast period (2020-2025). Rising demand for small molecule drugs in chronic disease treatment is expected to drive the market growth during the forecast period. Also, the increasing use of nano-particles in the manufacturing of anti-cancer drugs is expected to boost the market growth through the oncology segment.

Table 1. Global Small Molecule Drug Discovery Market Synopsis

Parameters

Description

Market Value (US$ Mn) for the Period

2018-2025

Base Year

2019

Forecast Period

2020-2025

Market Segmentation (By Therapeutic Type)

Central Nervous System (CNS), Cardiovascular, Oncology, Metabolic Disorders, Gastrointestinal, Orthopedics, Respiratory, Immunology, Others

Market Segmentation (By Phase)

HIT Generation & Selection, Validation, Lead Identification, Lead Optimization

Regions Covered

North America, Latin America, Europe, Asia-Pacific, Middle East and Africa

Key Players Coverage

AbbVie Inc, Pfizer Inc, GlaxoSmithKline plc, Bristol Myers Squibb Company, Astra Zeneca, Gilead Science, Inc, Johnson & Johnson Services Inc. among others.

Key Insights

  • Latest Updates
  • Analyst Views
  • Future Outlook of the Market

Market Dynamics

The global rising health concerns and increasing cases of diseases, is leading to continuous development and new drug discoveries. Especially, the developed regions such as the U.S. is expected to emerge as top leader in research & development in small drug discoveries. For instance, in 2018, according to the “Lancet” journal, the global health spending reached to US$ 8 billion. Similarly, the spending was focused on disease such as malaria, HIV, and tuberculosis. Additionally, small molecules used in the treatment of chronic diseases is expected to propel the market growth during the forecast period. However, high capital costs may hinder the market growth.

Figure 1. Small Molecule Drug Discovery Market Scenario Forecast (Likely, Conservative, and Optimistic Scenario), 2019 and 2025 (US$ Mn)

Note: The above figure is shown for illustrative purposes only, the actual data may vary and will be incorporated in the report.

North America is expected to dominate the small molecule drug discovery market followed by Europe, owing to its various set of regulations laid by the U.S. medicines agency and frequent launch of highly advanced systems in pharmaceutical field. Moreover, in 2018, U.S. FDA, approved total of 59 drugs for market use which is anticipated to drive the market growth for small molecule drugs.

Asia-Pacific small molecule drug discovery market is expected to grow at the highest CAGR during the forecast period, due to its increasing standard of living, rapid urbanization, rising health concerns, and deployment of new factories (pharmaceutical companies) in Asian countries. Middle East is also expected to have a significant growth during the forecast period attributed to rising health awareness that includes their future sustainable development plans. For instance, in April 2017, the international conference held on pharmaceutical development and technology in Dubai, was focused on research in small drug molecules for protein & vaccine delivery.

Figure 2. Regional Analysis

 

Note: Above figure shown for illustrative purpose only, the actual data may vary and will be incorporated in the report.

Competitve Landscape

Key players in global small molecule drug discovery market include: Pfizer Inc, Bristol Myers Squibb Company, Merck KGaA, Boehringer Ingelheim International GmbH, GlaxoSmithKline plc, Astra Zeneca, Gilead Science, Inc., Johnson & Johnson Services Inc., Abbvie Inc., Takeda Pharmaceutical Company, among others. Players are focusing on collaborations to research in the field of drug discovery which is expected to foster the market growth. For instance, in September 2019, Schrodinger announced the expansion of multi target research in collaboration with Takeda pharmaceuticals, through which they may carry out their research activities together in the manufacturing of various drugs. Moreover, growing health concerns across the globe, and players coming up with new techniques and drugs for disease treatment are expected to further boost the small molecule drug discovery market demand in the foreseen future.

Figure 3. Market Share of Key Players, 2019

 

Note: Above figure shown for illustrative purpose only, the actual data may vary and will be incorporated in the report.

By Therapeutic Type

  • Central Nervous System (CNS)
  • Cardiovascular
  • Oncology
  • Orthopedics
  • Respiratory
  • Immunology
  • Metabolic Disorders
  • Gastrointestinal
  • Others

By Phase

  • HIT Generation & Selection
  • Validation
  • Lead Identification
  • Lead Optimization

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa
rm
Kindly fill the below form and we will contact you within 24 hours
I have read and accept Privacy Policy

Confidentiality

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

Note: This report provides in-depth analysis of the global small molecule drug discovery market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2020-2025), considering 2019, as the base year.

  • What are the trends adopted by key players in the global small molecule drug discovery market?
  • Who are the top players contributing to the growth of the global small molecule drug discovery market, and what are the new strategies adopted by them to retain a market share in the industry?
  • What is the competitive strength of the key players in the small molecule drug discovery market?
  • What key factors are expected to increase the demand for small molecule drug discovery market during the forecast period 2020-2025?
  • What are the major challenges inhibiting the growth of the global small molecule drug discovery market?
  • What is the total market value (US$ Mn) generated in global small molecule drug discovery market by therapeutic type in 2019 and what are the forecasts by 2025?
  • Which phase is expected to dominate the small molecule drug discovery market in the coming years?
  • What was the total revenue generated by the global small molecule drug discovery market across different regions (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) in 2019, along with CAGR (%) for the period (2020-2025)?
  • What new products are going to be approved or launched in the coming years which may have huge impact on the market?
  • What insights are derived through the analysis of key players on following parameters: company overview, financial performance, product portfolio, geographical presence, key highlights, and strategies?
Latest Reports

Global Oncology Precision Medicine Market

Global Oncology Precision Medicine Market, By Ecosystem (Applied Sciences (Genomics, Pharmacogenomics and Other Applied Sciences), Precision Diagnostics (Molecular Diagnostics …

Read More

Global Small Molecule Drug Discovery Market

Global Small Molecule Drug Discovery Market, By Therapeutic Type (Central Nervous System (CNS), Cardiovascular, Oncology, Metabolic Disorders, Gastrointestinal, Orthopedics, …

Read More

Global Diabetes Drugs Market

Global Diabetes Drugs Market, By Diabetes Type (Type-1 & Type-2), By Drug (Oral Anti-Diabetic Drugs (Biguanides, Alpha-Glucosidase Inhibitors, Dopamine …

Read More

Global Bipolar Disorder Treatment Market

Global Bipolar Disorder Treatment Market, By Drug Type (Antipsychotic, Antidepressant, Anticonvulsants, Antianxiety, Mood Stabilizers, Others), By Bipolar Disorder Type …

Read More

Global Cytotoxic Drugs Contract Manufacturing Market

Global Cytotoxic Drugs Contract Manufacturing Market, By Product Type (Oral, Intravenous), By Form (Liquid, Solid), By Production Scale (Laboratory …

Read More

India Acetazolamide Market

India Acetazolamide Market, By Formulation (Tablets, Capsules, and Injection), By Application (Glaucoma, Epilepsy, Drug-induced Edema, Altitude …

Read More

India Diclofenac Market

India Diclofenac Market, By Indication (Osteoarthritis, Ankylosing Spondylitis, Dysmenorrhea, Rheumatoid Arthritis, Migraine, Pain, and Others), By Route of Administration …

Read More

Global Polycystic Ovarian Syndrome (PCOS) Treatment Market

Global Polycystic Ovarian Syndrome (PCOS) Treatment Market, By Drug Class (Contraceptives & Antiandrogens (Provera, Yasminell, Clomid, Aldactone, Diane 35, …

Read More
Validation error occured. Please enter the fields and submit it again.